# US 2008/0187934 A1 · Method and probes for the detection of chromosome aberrations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0187934 A1
- Document ID: US20080187934A1
- Status: Published application
- Kind: A1
- Application number: 12/071,268
- Filed: 2008-02-19
- Published: 2008-08-07
- Earliest claimed: 1998-05-04
- Assignees: Dako A/S
- Inventors: Jacobus Johannus Maria Van Dongen; Karl-Johan Pluzek; Kirsten Vang Nielsen; Kim Adelhorst
- Web page: https://patentgrep.com/patent/US20080187934A1

## CPC

- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6841: In situ hybridisation
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A novel method for detecting chromosome aberrations is disclosed. More specifically, chromosome aberrations are detected by in situ hybridisation using at least two sets of hybridisation probes, at least one set comprising one or more peptide nucleic acid probes capable of hybridising to specific nucleic acid sequences related to a potential aberration in a chromosome, and at least one set comprising two or more peptide nucleic acid probes capable of hybridising to specific nucleic acid sequences related to another potential aberration in a chromosome. In particular, the method may be used for detecting chromosome aberrations in the form of breakpoints.

## Claims

### Claim 1

A method of determining the presence of chromosome aberrations in a sample of eukaryotic origin using in situ hybridisation, comprising the steps of
a) producing a preparation of the sample, whereby the sample will be subject to a fixation,
b) contacting said preparation with a hybridisation solution comprising at least two sets of hybridisation probes, at lest one set comprising one or more peptide nucleic acid probes capable of hybridising to specific nucleic acid sequences related to a potential aberration in a chromosome, and at least one set comprising one or more peptide nucleic acid probes capable of hybridising to specific nucleic acid sequences related to another or the same potential aberration in a chromosome, and optionally a hybrid destabilising agent in an amount effective to decrease the melting temperature of hybrids formed between said nucleic acid sequences and said peptide nucleic acid probes so as to increase the ratio between specific an non-specific binding,
c) removing any unbound and any non-specifically bound peptide nucleic acid probe, and
d) determining the presence of peptide nucleic acid probes in the preparation.

### Claim at position 2

2-34. (canceled)
